In the clinical treatment for cerebral infarction, it is mainly divided into two phases, the acute phase is mainly for the application of some related therapeutic measures such as antithrombotic, anticoagulant and thrombus extraction. In the recovery period and the secondary prevention stage of patients, patients are given antiplatelet and lipid-lowering drugs, such as aspirin, simvastatin and other related drugs. At the same time, oral medications are also given to patients to lower blood sugar, blood pressure and other related medications, such as metformin and insulin in glucose-lowering drugs, and amlodipine and nifedipine in the process of lowering blood pressure. Brain atrophy is mostly a physiological degenerative change, mostly seen in elderly patients, in the treatment can be given early to improve brain metabolism, dredge the blood vessels of the relevant therapeutic drugs, such as commonly used drugs, including olanzapine, piracetam, cytarabine and so on. In terms of improving cerebral blood circulation, drugs such as Shuxuetong and Shu Xuning can be used. In addition, patients with cerebral infarction can also have symptoms of brain atrophy in the late stage, and in the treatment, patients are mainly given the secondary prevention of cerebrovascular drugs, and at the same time, they can be added to improve cerebral circulation and brain metabolism of the therapeutic drugs.